Consistent high levels of CD133 and ABCB5 marker expression were observed in 100% tissues from patients with primary melanoma that successively progressed to lymph node metastasis (100%) and distant metastasis (83% and 66%, respectively; Table III). This evidence concerns the gene ABCB5 and melanoma.